Biomarkers and heart disease: what is translational success?
作者信息
Spinale Francis G, Stolen Craig M
出版信息
J Cardiovasc Transl Res. 2013 Aug;6(4):447-8. doi: 10.1007/s12265-013-9477-9. Epub 2013 Jun 4.
Abstract
摘要
相似文献
1
Biomarkers and heart disease: what is translational success?生物标志物与心脏病：什么是转化医学的成功？
J Cardiovasc Transl Res. 2013 Aug;6(4):447-8. doi: 10.1007/s12265-013-9477-9. Epub 2013 Jun 4.
2
Evaluation of heart failure biomarker tests: a survey of statistical considerations.心力衰竭生物标志物检测的评估：统计考虑因素调查。
J Cardiovasc Transl Res. 2013 Aug;6(4):449-57. doi: 10.1007/s12265-013-9470-3. Epub 2013 May 14.
3
The use of magnetic resonance methods in translational cardiovascular research.磁共振方法在转化心血管研究中的应用。
J Cardiovasc Transl Res. 2009 Mar;2(1):39-47. doi: 10.1007/s12265-008-9084-3. Epub 2009 Jan 13.
4
Biomarker and drug discovery for gastroenterology through translational bioinformatics.通过转化生物信息学进行胃肠病学的生物标志物与药物发现
Gastroenterology. 2010 Sep;139(3):735-41, 741.e1. doi: 10.1053/j.gastro.2010.07.024. Epub 2010 Jul 19.
5
Markers for cardiac damage: current status and future trends. Proceedings of the 7th Bergmeyer Conference on Improving the Clinical Value of Laboratory Data. Tutzing, Germany, 1999.
Scand J Clin Lab Invest Suppl. 1999;230:1-181.
6
MicroRNAs in cardiac remodeling and disease.微小 RNA 在心脏重构和疾病中的作用。
J Cardiovasc Transl Res. 2010 Jun;3(3):212-8. doi: 10.1007/s12265-010-9165-y. Epub 2010 Feb 17.
7
Cardiac risk factors: biomarkers and genetic tests to determine cardiovascular risk.心脏危险因素：用于确定心血管风险的生物标志物和基因检测
FP Essent. 2014 Jun;421:11-5.
8
Genetic testing for inherited cardiac disease.遗传性心脏病的基因检测。
Nat Rev Cardiol. 2013 Oct;10(10):571-83. doi: 10.1038/nrcardio.2013.108. Epub 2013 Jul 30.
9
Heart disease, clinical proteomics and mass spectrometry.心脏病、临床蛋白质组学与质谱分析
Dis Markers. 2004;20(3):167-78. doi: 10.1155/2004/965261.
10
Alternative Biomarkers for Combined Biology.联合生物学的替代生物标志物。
Heart Fail Clin. 2017 Apr;13(2):381-401. doi: 10.1016/j.hfc.2016.12.009.
引用本文的文献
1
The influence of exendin-4 intervention on -obese diabetic mouse blood and the pancreatic tissue immune microenvironment.艾塞那肽-4干预对肥胖糖尿病小鼠血液及胰腺组织免疫微环境的影响。
Exp Ther Med. 2016 Nov;12(5):2893-2898. doi: 10.3892/etm.2016.3694. Epub 2016 Sep 12.
2
Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT.可溶性ST2与轻度症状性心力衰竭患者发生心律失常、心力衰竭或死亡的风险：MADIT-CRT研究结果
J Cardiovasc Transl Res. 2016 Dec;9(5-6):421-428. doi: 10.1007/s12265-016-9713-1. Epub 2016 Oct 31.
3
Myocardial and Peripheral Ischemia Causes an Increase in Circulating Pregnancy-Associated Plasma Protein-A in Non-atherosclerotic, Non-heparinized Pigs.心肌和外周缺血导致非动脉粥样硬化、未肝素化猪循环中妊娠相关血浆蛋白-A增加。
J Cardiovasc Transl Res. 2015 Dec;8(9):528-35. doi: 10.1007/s12265-015-9656-y. Epub 2015 Oct 6.
4
Circulating matrix metalloproteinase patterns in association with aortic dilatation in bicuspid aortic valve patients with isolated severe aortic stenosis.孤立性严重主动脉瓣狭窄的二叶式主动脉瓣患者中循环基质金属蛋白酶模式与主动脉扩张的关系
Heart Vessels. 2016 Feb;31(2):189-97. doi: 10.1007/s00380-014-0593-5. Epub 2014 Oct 18.
本文引用的文献
1
Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.血浆基质金属蛋白酶和金属蛋白酶组织抑制剂谱可预测电复律后心房颤动的复发。
J Cardiovasc Transl Res. 2013 Aug;6(4):528-35. doi: 10.1007/s12265-013-9471-2. Epub 2013 May 31.
2
Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.舒张功能障碍和心肌纤维化的生物标志物：在心衰伴射血分数保留中的应用。
J Cardiovasc Transl Res. 2013 Aug;6(4):501-15. doi: 10.1007/s12265-013-9472-1. Epub 2013 May 29.
3
MicroRNAs as biomarkers for ischemic heart disease.微小 RNA 作为缺血性心脏病的生物标志物。
J Cardiovasc Transl Res. 2013 Aug;6(4):458-70. doi: 10.1007/s12265-013-9466-z. Epub 2013 May 29.
4
Evaluation of heart failure biomarker tests: a survey of statistical considerations.心力衰竭生物标志物检测的评估：统计考虑因素调查。
J Cardiovasc Transl Res. 2013 Aug;6(4):449-57. doi: 10.1007/s12265-013-9470-3. Epub 2013 May 14.
5
Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease.脂质修饰生物标志物与稳定型冠状动脉疾病冠状动脉狭窄严重程度的功能和形态学指标的相关性。
J Cardiovasc Transl Res. 2013 Aug;6(4):536-44. doi: 10.1007/s12265-013-9468-x. Epub 2013 May 14.
6
Positioning of inflammatory biomarkers in the heart failure landscape.炎症生物标志物在心衰领域的定位。
J Cardiovasc Transl Res. 2013 Aug;6(4):485-92. doi: 10.1007/s12265-013-9467-y. Epub 2013 May 11.
7
Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.单核细胞趋化作用的抑制——心保护激素 B 型利钠肽的一种新型抗炎作用机制。
J Cardiovasc Transl Res. 2013 Aug;6(4):545-57. doi: 10.1007/s12265-013-9456-1. Epub 2013 Apr 27.
8
New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.左心室收缩功能障碍的新型和新兴生物标志物——扩张型心肌病的深入了解。
J Cardiovasc Transl Res. 2013 Aug;6(4):516-27. doi: 10.1007/s12265-013-9462-3. Epub 2013 Apr 23.
9
Heart failure biomarkers.心力衰竭生物标志物。
J Cardiovasc Transl Res. 2013 Aug;6(4):471-84. doi: 10.1007/s12265-013-9465-0. Epub 2013 Apr 20.
10
ST2 as a cardiovascular risk biomarker: from the bench to the bedside.ST2 作为心血管风险生物标志物：从实验室到临床。
J Cardiovasc Transl Res. 2013 Aug;6(4):493-500. doi: 10.1007/s12265-013-9459-y. Epub 2013 Apr 5.
Zotero 插件